Regeneron Pharmaceuticals News Timeline

Regeneron Pharmaceuticals Inc -- USA Stock  

USD 432.98  7.96  1.81%

This is yet another view into Regeneron Pharmaceuticals filtered headlines to help investors concentrate on Regeneron Pharmaceuticals Inc noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Regeneron Pharmaceuticals headlines in addition to utilizing other more conventional financial analysis modules. Additionally take a look at Regeneron Pharmaceuticals Backtesting and Regeneron Pharmaceuticals Hype Analysis
wsj  News
October 20, 2017
Exercise of in-the-money or at-the-money derivative position by Erlinger Iii James H of 10000 shares of Quintiles IMS at www.stocknewsjournal.com 
View Story
news
September 29, 2017
Exercise of in-the-money or at-the-money derivative position by Erlinger Iii James H of 10000 shares of Quintiles IMS at morganleader.com 
View Story
Macroaxis News
October 20, 2017
Payment of 545 shares by Terrance Coughlin of Endo International subject to Rule 16b-3 at MacroaxisInsider 
View Story
seekingalpha News
October 20, 2017
I Love Earnings Season Let See How Abbott Laboratories, Johnson and Johnson ... at seekingalpha.com 
View Story
news
October 20, 2017
Citigroup Has Just Reaffirmed 240 Target Price Per Share on Allergan plc ... at bzweekly.com 
View Story
news
September 29, 2017
Bio-Rad Laboratories, Inc. Shares Sold by UBS Asset Management Americas Inc. at ledgergazette.com 
View Story